Retraction Note: Aldose reductase inhibitor Epalrestat alleviates high glucose-induced cardiomyocyte apoptosis via ROS.
Wang, X, F Yu, and W-Q Zheng. 2024. “Retraction Note: Aldose Reductase Inhibitor Epalrestat Alleviates High Glucose-Induced Cardiomyocyte Apoptosis via ROS.”. European Review for Medical and Pharmacological Sciences 28 (21): 4491.